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Abstract
Background: Ageing is associated with a significant reduction in skeletal muscle carnosine which
has been linked with a reduction in the buffering capacity of muscle and in theory, may increase the
rate of fatigue during exercise. Supplementing beta-alanine has been shown to significantly increase
skeletal muscle carnosine. The purpose of this study, therefore, was to examine the effects of
ninety days of beta-alanine supplementation on the physical working capacity at the fatigue
threshold (PWCFT) in elderly men and women.
Methods: Using a double-blind placebo controlled design, twenty-six men (n = 9) and women (n
= 17) (age ± SD = 72.8 ± 11.1 yrs) were randomly assigned to either beta-alanine (BA: 800 mg × 3
per day; n = 12; CarnoSyn™) or Placebo (PL; n = 14) group. Before (pre) and after (post) the
supplementation period, participants performed a discontinuous cycle ergometry test to determine
the PWCFT.
Results: Significant increases in PWCFT (28.6%) from pre- to post-supplementation were found for
the BA treatment group (p < 0.05), but no change was observed with PL treatment. These findings
suggest that ninety days of BA supplementation may increase physical working capacity by delaying
the onset of neuromuscular fatigue in elderly men and women.
Conclusion: We suggest that BA supplementation, by improving intracellular pH control,
improves muscle endurance in the elderly. This, we believe, could have importance in the
prevention of falls, and the maintenance of health and independent living in elderly men and women.

Background
Carnosine (beta-alanyl-L-histidine), a dipeptide is an efficient hydrogen ion (H+) buffer over the physiological pH
range [1,2]. In muscle, where its concentration is highest,
carnosine makes an important contribution to the main-

tenance of intracellular pH, which is vital for normal muscle function during intense exercise [1]. While the
dipeptide is found in both Type I and Type II muscle, its
concentration is highest in Type II muscle. Studies in
humans and rats have demonstrated an inverse relation-
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ship between age and muscle carnosine content [3,4]. Sarcopenia, the loss in muscle mass with age, is associated
with significant reductions in strength, power, and the
ability to resist fatigue in elderly men and women [5,6].
Significant decreases in skeletal muscle and decline in
muscle function are clearly evident after the age of fifty
[5,7]. Deterioration of motor coordination, as a result of
losses in strength and/or fatigue, is related to an increase
in the frequency of falls [6,8] which repeatedly lead to
injury and even deaths among the elderly [9].
A number of investigations have used surface electromyographic (EMG) procedures to identify the power output
associated with the onset of neuromuscular fatigue (NMF)
during cycle ergometry [10-12]. NMF is typically characterized by an increase in the electrical activity of the working muscles over time [11,13]. Moritani et al. [11]
suggested that the fatigue-induced increase in EMG amplitude is a result of progressive recruitment of additional
motor units (MU) and/or an increase in the firing frequency of MUs that have already been recruited. De Vries
et al. [13] developed a submaximal discontinuous cycle
ergometer test utilizing this concept of progressive muscle
activation and introduced the concept of "the physical
working capacity at the fatigue threshold" (PWCFT). This
utilized the EMG fatigue curves to identify the power output that corresponded to the onset of the NMF threshold.
PWCFT represents the highest power output that does not
result in a significant increase in the electrical activity of
the thigh muscle over time (p > 0.05). PWCFT has been
shown to be reliable [10], valid [10] and sensitive to
changes in fitness levels and creatine supplementation
[14] in older men and women (62 – 73 years). Furthermore, de Vries et al. [10] suggested that PWCFT in elderly
men and women may be more appropriate than the
assessment of physical work capacity by measurement of
maximal oxygen uptake capacity (i.e., V02 max). In addition, de Vries et al. [10] reported PWCFT was a more sensitive measure of monitoring changes, in comparison to
fitness tests that depend upon heart rate/power output
relationships and/or maximal cardiac output.
Recently, Harris et al. [2] and Hill et al. [15] have shown
that beta-alanine (BA) supplementation can significantly
increase skeletal muscle carnosine levels, and that the
increase is correlated to improvements in exercise performance. In addition, Stout et al. [16,17] used the PWCFT
test to examine the effect of BA supplementation in young
(18 to 30 years) men and women, and reported significant
increases in PWCFT of 12 to 15% with BA supplementation. Accordingly, Stout et al. [16,17] suggested that the
increase in PWCFT was the result of a BA induced increase
in skeletal muscle carnosine, increasing the muscle's
capacity to buffer H+ during exercise. However, the effect
of BA supplementation on PWCFT in elderly men and
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women is presently unknown. In theory, increasing skeletal muscle carnosine levels, should improve muscle buffering capacity, leading to a delay in fatigue in certain types
of exercise. These adaptations may translate into
improved functional capacity during daily living tasks and
quality of life. The purpose of this study, therefore, was to
examine the effects of ninety days of BA supplementation
on PWCFT in elderly men and women.

Methods
Subjects
Twenty-six elderly men and women (Table 1) from independent-living communities in South Florida volunteered
to participate in the study. None of the participants had
any previous history of BA supplementation and maintained their regular activity and dietary patterns throughout the study. It should be noted; however, that BA is
available from meat contained in the diet, although the
amount ingested is highly variable according to the meat
ingested, and of course quantity. Each participant had a
physician's approval to participate in the study, and completed a health history questionnaire prior to partaking.
None of the subjects had major orthopedic surgery within
the previous year, history of asthma, heart or pulmonary
disease, uncontrolled hypertension, and were not taking
any medications that would interfere with exercise. All
procedures were approved by the Institutional Review
Board for Human Subjects. Prior to the initiation of the
study, each participant was advised of any possible risks
before providing written informed consent.
Experimental design
Immediately following pre-testing, the participants were
randomly assigned to one of two treatment conditions
using a double-blind placebo controlled design: (a) BA:
2.4 grams of beta-alanine in clear gelatin capsule (CarnoSyn™, Natural Alternatives International, San Marcos, CA,
USA), n = 12; or (b) PL: 2.4 grams of microcrystalline cellulose in clear gelatin capsule, n = 14. Each capsule contained 800 mg and was identical in appearance. One
capsule was ingested three times per day for ninety days
with meals, then within 3 to 5 days participants were posttested. During the course of the study, the participants
were asked to maintain their normal dietary and activity
pattern and refrain from starting additional nutritional
supplements and nonprescription drugs. In addition, the
participants were instructed to refrain from exhaustive
physical exercise, caffeine, and alcohol consumption for
Table 1: Subject characteristics mean (± SD)

BA (n = 12)
Placebo (n = 14)

Age (yrs)

Body Mass (kg)

Height (cm)

72.1 ± 10.6
73.4 ± 11.9

74.2 ± 16.2
73.4 ± 16.5

159.6 ± 9.6
153.4 ± 10.7
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24 hours prior to testing. Upon each visit to the testing
area, the participants were questioned to assure that they
had complied with the investigator's instructions and that
they followed the supplementation protocol as directed.
Subjects also kept a three-day food diary prior to the preand post-testing to ensure caloric intake was consistent.

49.4 W) and an ICC of 0.97 in 16 well-trained elderly men
and women (67.6 ± 5.6 years). The difference in mean
PWCFT values between the current participants versus the
de Vries et al. [13] could be due to the mean age difference
or trained [13] versus untrained (current study) status of
the participants.

Electromyographic (EMG) measurements
A bipolar (2.54 cm center-to-center) surface electrode
(Quinton Quick prep silver-silver chloride) arrangement
was placed on the right thigh over the lateral portion of
the vastus lateralis muscle, midway between the greater
trochanter and the lateral condyle of the femur. The reference electrode was placed over the spinous process of the
7th cervical vertebrae. Interelectrode impedance was kept
below 5000 ohms by careful abrasion of the skin. The raw
EMG signals were pre-amplified (gain: × 1000) using a
differential amplifier (EMG100C, Biopac Systems, Inc.,
Santa Barbara, CA), sampled at 1000 Hz, and stored on a
personal computer for off-line analysis. The EMG signals
were later bandpass filtered from 10–500 Hz (2nd order
Butterworth filter) and expressed as root mean square
(rms) amplitude values (uVrms) by software (AcqKnowledge v3.7, Biopac Systems, Inc., Santa Barbara, CA).

Statistical Analysis
Data were analyzed using 2 × 2 [treatment (BA vs. PL) ×
time (pre- vs. post)] repeated measures analysis of variance (ANOVA). If a significant interaction or main effect
occurred, follow-up analyses using dependent samples ttests were run. Prior to all statistical analyses, the alpha
level was set to p = 0.05 to determine statistical significance. Data were analyzed using SPSS version 12.0 (SPSS
Inc., Chicago, IL) software.

Determination of PWCFT
The PWCFT values were determined using the EMG amplitude values from the vastus lateralis muscle from the
methods previously described by de Vries et al. [13]. The
initial work rate for each participant was determined by
the principal investigator, based on the participant's estimate of his or her physical fitness. The subjects began
pedaling (with toe clips) at 50 rpm on a calibrated, electronically-braked cycle ergometer (Corval 400, Quinton
Instruments, Seattle, WA). Power output was increased 10
to 20 W for each two-minute stage of the discontinuous
protocol. Rest intervals between bouts were sufficiently
long to allow resting heart rate to return within 10 bpm of
that obtained upon arrival to the laboratory. During each
two-minute bout, six 10-second EMG samples were
recorded from the vastus lateralis. The PWCFT was determined by averaging the highest power output that
resulted in a non-significant (p > 0.05; single-tailed t-test)
slope value for the EMG amplitude vs. time relationship
and with the lowest power output that resulted in a significant (p ≤ 0.05) slope value [13].

Test-retest reliability for the PWCFT test was determined
from 11 participants measured 14 days apart. The intraclass correlation coefficient (ICC) was 0.83 (SEM = 8.4 W).
No significant difference (p > 0.05) was noted between
the mean PWCFT values from trial 1 (45.9 ± 17.3 W) to
trial 2 (48.3 ± 18.1 W). These results were similar to de
Vries et al. [13] who reported no significant (p > 0.05) difference from trial 1 (108.8 ± 53.3 W) and trial 2 (109.1 ±

Results
A significant interaction was evident between treatment
and time for PWCFT (p = 0.007). A dependent samples ttest demonstrated an increase in PWCFT (28.6%) from
pre- to post-supplementation with BA (p < 0.05), but no
significant change for the PL group (Figure 1). Furthermore, 67% of the individuals in the BA group demonstrated improvements from pre- to post-PWCFT values,
compared to 21.5% of the individuals in the PL group
(Figure 2).

Discussion
Data from this study suggest that ninety days of BA supplementation may increase physical working capacity in
elderly men and women. These findings may be clinically
significant, as a decrease in functional capacity to perform
daily living tasks has been associated with an increase in
mortality [18], primarily due to increased risk of falls [9].
Further, deVries et al. [13] and Alexander et al. [8] have
suggested that falls may be related to fatigue-induced
deterioration of motor coordination. Thus, an improved
resistance to fatigue, as reported in this study, (Figure 1
and 2) may be important to consider when working with
a similar population.
The concept of physical working capacity (PWC), a measure of aerobic power, muscular endurance and efficiency
is typically measured by oxygen consumption rate (VO2)
during a maximal graded exercise test (GXT) [19].
Recently, several studies have reported on the effects of BA
supplementation on PWCFT during incremental cycle
ergometry tests in young men and women [16,17]. Stout
et al. [16,17] reported that 28 days of BA supplementation
in a younger population (21–27 years) resulted in a significant increase in PWCFT by 12 – 15%, respectively. In
agreement, the current study demonstrated a 28.5%
increase in PWCFTafter ninety days of BA supplementation. The two-fold increase in PWCFT in the elderly com-
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Figure
1
Preto post-test
values for physical working capacity at fatigue threshold (PWCFT) for BA and PL groups
Pre- to post-test values for physical working capacity at fatigue threshold (PWCFT) for BA and PL groups. * Indicates a significant difference from pre- to post. (p < 0.01).

pared to young men and women in previous studies may
be due to differences in initial skeletal muscle carnosine
levels or supplementing duration. In support, Tallon et al.
[4] reported that in Type II skeletal muscle, carnosine concentration was 47% lower in elderly (70.4 ± 5.0 yrs) compared to younger (23.8 ± 4.6 yrs) men and women,
although Kim [20] found normal muscle carnosine levels
in elderly Korean subjects with impaired glucose tolerance. Harris et al. [2] demonstrated that 28 days of BA
supplementation significantly (60%) increased skeletal
muscle carnosine levels while Hill et al. [15] demonstrated a further 20% increase when BA supplementation
was continued for an additional 35 days. In light of these
reports, the greater change in PWCFT in elderly participants in the present study, compared to previous studies
in young men and women, was most likely due to both
initial carnosine levels and length of time of BA supplementation.
De Vries et al. [13] suggested the PWCFT test may be more
appropriate and sensitive to training effects on PWC in
elderly, compared to other methods (i.e. VO2 max) that
require maximal effort and may be ill-advised or possibly
hazardous in this population. To our knowledge, this is
the first study to examine the effects of BA supplementation using the PWCFT test in elderly men and women.

However, de Vries et al. [13] did examine the effects of 10
weeks of moderate intensity (70% PWCFT) endurance
training three times per week on PWCFT in elderly men
and women (67.9 ± 5.3 years). The results showed a significant (p < 0.05), 30% increase in PWCFT as a result of
the endurance training. While the results by de Vries et al.
[13] support and recommend endurance training as a
means to significantly improve physical working capacity,
it should be noted that the elderly subjects in the current
study were untrained, and the 28.5% increase in PWCFT
occurred without any type of additional training during
the ninety days of supplementation.
It has been proposed that exercise-induced decreases in
intramuscular pH may interfere with the excitation-contraction coupling process of skeletal muscle, which, in
turn may lead to decreases in power output and fatigue
[21]. Maintaining the intracellular pH during exercise
could therefore be important for normal muscle function
in the elderly [4]. In order to maintain pH homeostasis,
various buffering systems are involved, including active
H+ export from muscle [2]. However, the immediate line
of defense remains the buffering of H+ by intracellular
physico-chemical buffers, principally phosphates and carnosine. Marsh et al. [22] demonstrated that there was a
significant delay in the onset of intracellular acidosis dur-
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Figure
vidual
The percent
in2the BA
change
and values
placebofortreatment
the physical
groups,
working
respectively
capacity at fatigue threshold (PWCFT) from pre- to post-test for each indiThe percent change values for the physical working capacity at fatigue threshold (PWCFT) from pre- to post-test for each individual in the BA and placebo treatment groups, respectively. Sixty-seven percent of the individuals in the BA group demonstrated improvements from pre- to post-PWCFT values, compared to 21.5% of the individuals in the placebo group.

ing progressive exercise after six weeks of moderate intensity training, resulting in an increased capacity for
submaximal work in a similar cohort of elderly individuals. Improving the ability to buffer intramuscular H+ accumulation, therefore, appears to be an important factor for
delaying the onset of fatigue and increasing exercise
capacity in older men and women.
Based on these results, it is not unreasonable to expect
that introducing BA supplementation to increase muscle
carnosine levels, prior to starting an exercise program in
elderly men and women, would lead to an improvement
in the quality of training. This would be especially true if
muscle carnosine contents were already reduced with elderly persons. The limiting factor for muscle carnosine synthesis is the availability of BA, obtained either from uracil
degradation in the liver or from the release of BA from the
ingestion of carnosine (and related dipeptides in meat)
[2]. From preliminary observations showing that the level
of carnosine is reduced by up to 50% in vegetarian subjects [23], compared to age matched controls, it seems
likely that the capacity of the body to produce BA is limited and capable of supporting only a limited capacity to
synthesize carnosine. This is overcome in meat eaters
through the dietary supply of BA. However, elderly subjects, maintained on a diet with a restricted meat intake
would be expected to show a similar reduction in their
muscle carnosine content as vegetarians, and to respond
beneficially to BA supplementation.

Conclusion
The results of this study suggest that ninety days of BA supplementation may have significantly increased intramuscular carnosine resulting in a 28.5% increase in PWCFT
due to a greater H+ buffering capacity. However, future
studies are needed to confirm our results while measuring
changes in skeletal muscle carnosine content.
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